Focused Ultrasound for Pancreatic Cancer In an encouraging step toward expanding treatment options for pancreatic cancer, a newly published preclinical study demonstrates that histotripsy can safely target pancreatic tissue while preserving major blood vessels. Read more: https://ow.ly/zSll50YmIlZ

Final Day for Public Comments The Foundation is seeking opinions on a draft landscape analysis of AAV-based gene therapies for neurodegenerative diseases that could benefit from focused ultrasound. Public comments open through February 27: https://ow.ly/4jBR50YmYr0

The Foundation congratulates Zhen Xu, PhD, the Li Ka Shing Endowed Professor of Biomedical Engineering at the University of Michigan, on being named to the 2026 TIME100 Health List and receiving the prestigious Sony Women in Technology Award with Nature. Read more: https://ow.ly/O7Hv50YmKkJ

Researchers at Virginia Tech are recruiting large dogs (over 44 pounds) for a clinical trial exploring focused ultrasound histotripsy for liver tumors. Participants will undergo histotripsy treatment before standard surgical tumor resection. Learn more about enrollment: https://ow.ly/cgh950Ym1gg

Now Accepting Applications: 2026 Summer Global Internships This internship provides students the opportunity to conduct focused ultrasound research with leading academic and industry mentors at recognized sites around the world. Applications are open through April 17: https://ow.ly/Kkru50Yl9vN

A white paper summarizing the Foundation’s workshop on the role of focused ultrasound in advancing cell and gene therapy is now available. Experts explored gene therapy for neurodegenerative diseases and large organs, as well as cell therapies for brain tumors. https://ow.ly/bGJO50YiWiN

Deadline Extension for Abstracts: Investigators are invited to submit their abstracts for the European Symposium on Focused Ultrasound Therapy, to be held April 9–10 in Vienna, Austria. Abstract submission deadline: February 28 Learn more and submit your abstract: https://eufus.org/

A new clinical trial has begun to better understand how focused ultrasound–mediated blood-brain barrier opening affects the tumor microenvironment in patients with gliomas. This research may inform future studies exploring the delivery & evaluation of therapeutic agents. https://ow.ly/sJMP50Yijk7

New on the Podcast! In this episode, we speak with Philip Bergman, DVM, MS, PhD, DACVIM-Oncology, Veterinary Program Director at the Foundation, about the expanding role of focused ultrasound in veterinary medicine. Listen and subscribe: https://ow.ly/SegO50YhezT

A new clinical trial is testing noninvasive ultrasound neuromodulation for the treatment of rheumatoid arthritis (RA). The trial is currently underway at two sites in Texas, with the long-term goal of enabling patients to use the device at home. Learn more: https://ow.ly/jIB450YfbS4

The Foundation recently hosted a workshop on the use of focused ultrasound to treat diffuse intrinsic pontine glioma (DIPG), a rare and aggressive pediatric brain tumor. A comprehensive white paper summarizing the workshop is now available. Access the full white paper: https://ow.ly/X0TR50YflC0

Final Call for Abstracts: – EUFUS Symposium Investigators are invited to submit their abstracts for the European Symposium on Focused Ultrasound Therapy, taking place April 9–10 in Vienna, Austria. Abstract submission deadline: February 16 Learn more and submit your abstract: https://eufus.org/

Last week, the Foundation presented a special webinar exploring how advances in brain targeting are improving focused ultrasound treatment for movement disorders. Access the full recording: https://ow.ly/oQ2N50Yf6v8

We are seeking opinions on a draft landscape of AAV-based gene therapies for neurodegenerative diseases that could benefit from focused ultrasound. Your feedback will help refine this resource & inform future funding priorities. Public comments open through Feb 27: https://ow.ly/7Brs50YcZfu

Register for the next ISTU webinar, "Clinical Experience with Histotripsy,” featuring Timothy Ziemlewicz, MD, Professor of Radiology at the University of Wisconsin. This free event will be held live on Feb 19/20 at various local times. Learn more: https://istu.org/istu-live-webinar-series/

Focused Ultrasound for Pain: Webinar Recording Now Available Last week, the Foundation hosted a webinar exploring how new, noninvasive technologies like focused ultrasound are transforming the treatment of pain. https://www.youtube.com/watch?v=pCVDFQL_7nE

The Foundation is pleased to share that SonoMotion’s Break Wave™ lithotripsy system has received FDA clearance for the treatment of kidney stones. The device uses low-pressure focused ultrasound to noninvasively fragment stones under real-time ultrasound guidance. https://ow.ly/K4FO50Ya5GI

In the latest episode of Curing with Sound, we speak with Natasha Sheybani, PhD, assistant professor of biomedical engineering at the University of Virginia and research director of the UVA Focused Ultrasound Cancer Immunotherapy Center. 🎧Listen: https://ow.ly/a2N450Y8rgO

Recently published results from an early-stage clinical trial show that focused ultrasound–mediated blood-brain barrier opening combined with chemotherapy is safe in patients with glioblastoma. Researchers are now recruiting participants for a larger clinical trial. https://ow.ly/8qyZ50Y6gRs

The Foundation’s Research Awards Program initiated six new preclinical studies in the fourth quarter of 2025. Research teams from around the world are continuing to develop focused ultrasound treatments for primary and metastatic cancers. Learn more: https://ow.ly/ViaN50Y62vH

Join us Fri, Feb 6 at 1 pm ET for this free event held in partnership with RebrAIn, Insightec, and Upstream Vision. The webinar explores how advances in brain targeting are improving focused ultrasound treatment for essential tremor and Parkinson’s disease. Register: https://ow.ly/UiNU50Y3mXK

Cardiawave has been granted CE Marking for Valvosoft®, a first-of-its-kind noninvasive focused ultrasound device for the treatment of severe symptomatic aortic valve stenosis. The device uses focused ultrasound to soften calcified valve leaflets and improve function. https://ow.ly/SCEN50Y3mNr

Join us Feb 3, at 12 pm ET, for “Living a Pain-free Life with Dr. Sanjay Gupta and the Role of Focused Ultrasound with Dr. Lauren Hadley,” a free live webinar exploring how new, noninvasive technologies like focused ultrasound are transforming the treatment of pain. Register: https://bit.ly/4rbmNsQ

In this episode, we speak with Natasha Sheybani, PhD, assistant professor of biomedical engineering at UVA. Dr. Sheybani shares insights into her work using focused ultrasound–based immunotherapy approaches in patients with metastatic breast cancer and other solid tumors. https://ow.ly/wLl350Y4osa

New research shows that pre-operative perfusion MRI can help predict how microbubbles distribute in the human brain — a key step toward more precise, image-guided focused ultrasound for blood–brain barrier opening. Read more about this Foundation-funded study: https://ow.ly/Iwih50Y3mJy

Researchers have developed a new focused ultrasound—based method of liquid biopsy. When used with an innovative medical device for testing and analysis, physicians could soon quickly determine whether brain tumor treatments are working. https://bit.ly/3YVZ8QX

This episode features Jean-Francois Aubry, PhD, Director of Research at CNRS and co-founder of SonoMind. He shares insights from his trial exploring focused ultrasound neuromodulation for treatment-resistant depression & discusses his work at https://ow.ly/laHY50Y1lum. https://ow.ly/KsUQ50Y1lul

On Feb 3 at 12 pm ET, join us for a free webinar featuring CNN chief medical correspondent, neurosurgeon, and author Sanjay Gupta, MD, who will share insights from his new book, It Doesn’t Have to Hurt: Your Smart Guide to a Pain-Free Life. Register: https://ow.ly/s3NN50Y0rum

A comprehensive white paper summarizing the Foundation’s workshop on the use of focused ultrasound to treat diffuse intrinsic pontine glioma (DIPG) is now available. DIPG is an aggressive, malignant brain tumor that primarily affects children. Access the full paper: https://ow.ly/pEQf50Y0qyv

Focused Ultrasound News, Straight to Your Inbox Subscribe to our Focused Ultrasound News Digest for curated media coverage on focused ultrasound patient, research, and industry updates delivered to your inbox several times a week. Sign up today: https://ow.ly/HqqN50XZRoK

2025 was a landmark year in the field of focused ultrasound. Last year’s most-read articles featured research news for brain tumors, pancreatic cancer, addiction, and Alzheimer’s, as well as patient stories, new regulatory approvals, and more. https://ow.ly/nbwn50XWoNb

Philip Bergman, DVM, PhD, is the director of the Foundation's Veterinary Program. He brings deep expertise in clinical research and translational medicine, supporting the advancement of focused ultrasound. Read our recent sit-down interview with Dr. Bergman: https://ow.ly/z6iA50XY4qk

On Fri, Feb 6, at 1 pm ET, the Foundation will present a webinar exploring how advances in brain targeting are improving focused ultrasound treatment for movement disorders.
Experts will discuss how emerging techniques are helping optimize patient outcomes. Register: https://ow.ly/Omi750XWhK4

In this episode, we speak with Jean-Francois Aubry, PhD, Director of Research at France’s CNRS and co-founder of SonoMind. Dr. Aubry shares insights from his clinical trial investigating focused ultrasound neuromodulation for treatment-resistant depression. https://ow.ly/Cj5150XWnsO

Register for the next ISTU webinar, "FUS Mobile: The Road to Commercialization,” featuring Arik Hananel, MD, MBA. Dr. Hananel is the CEO of FUSMobile with over 25 years of experience in focused ultrasound. This event will be held live on Jan 22/23 at various local times: https://ow.ly/6XZY50XU9uL

Rick has essential tremor, a benign tremor that often left him embarrassed in public and frustrated with everyday tasks. After undergoing a focused ultrasound treatment, Rick can now hold his hand steady for the first time since childhood. Watch Rick’s journey: https://ow.ly/pWmo50XU6sJ

The Foundation is proud to designate University College London and King’s College London as a Focused Ultrasound Center of Excellence. Both institutions are leaders in focused ultrasound for the treatment of prostate cancer, movement disorders, liver tumors, & more. https://ow.ly/MA7N50XU0Zj

FUSMobile’s Neurolyser XR system has been granted De Novo clearance by the FDA for the treatment of chronic low back pain. The first-of-its-kind device uses focused ultrasound to ablate sensory nerves in the spinal facet joints. Learn more: https://ow.ly/eYnm50XSFmQ

The Foundation and the Society of Interventional Oncology recently presented a webinar on minimally invasive approaches for treating pancreatic cancer. Expert physicians shared insights on several treatment modalities, including focused ultrasound. Recording now available: https://ow.ly/4Hhg50XS4pc

Recently published clinical trial results report, for the first time, a possible survival benefit among newly diagnosed glioblastoma patients treated with focused ultrasound + temozolomide (or TMZ, a chemotherapy drug). https://ow.ly/ZHCY50XRUfr

In our latest episode, we sit down with Pascale Broks, Development Director for Europe, to discuss the launch of the European Union Focused Ultrasound Foundation. Learn how the organization is advancing patient-centered access to focused ultrasound across the EU. https://ow.ly/HJGk50XRb15

Painful flares from osteoid osteoma disrupted Jack’s active life and kept him from the sports he loved. As the first pediatric patient in North America to receive focused ultrasound treatment, Jack experienced remarkable relief. Learn more: https://www.fusfoundation.org/profiles/jacks-story/

For the first time in pediatric patients with diffuse midline glioma, focused ultrasound was found to safely open the blood–brain barrier without sedation. Results showed strong feasibility & tolerability, with clinical improvement observed in two of three participants. https://ow.ly/aMwf50XQ9Wx

The Foundation is pleased to welcome Gerry Brunk to our Council. Mr. Brunk is the co-founder and managing director of Lumira Ventures, where he has led investments in over 30 biotechnology and medical device companies. https://ow.ly/z9XM50XMFp0

Cardiawave has been granted CE Marking for Valvosoft®, a first-of-its-kind noninvasive focused ultrasound device for the treatment of severe symptomatic aortic valve stenosis. The device uses focused ultrasound to soften calcified valve leaflets and improve function. https://ow.ly/iQEQ50XNbZI

We sat down with Pascale Broks, the Foundation’s Development Director for Europe and founder of the European Union Focused Ultrasound Foundation (EUFUSF). Tune in to hear how EUFUSF is building awareness, engaging partners, and driving access to this technology: https://ow.ly/fuWc50XMAo8

Making a gift to the Foundation helps accelerate the research needed to pursue new indications, advance clinical translation so treatments reach patients more quickly, and expand global access to this groundbreaking technology. Make a gift today: https://www.fusfoundation.org/donate

Alec Batts, PhD, has been awarded the 2025 Andrew J. Lockhart Postdoctoral Fellowship in Focused Ultrasound and Immuno-Oncology. Dr. Batts' research will focus on combining gene and cell therapies with focused ultrasound devices to transform cancer treatment. Read more: https://ow.ly/joy050XMxLj

The Foundation is pleased to designate Washington University in St. Louis as a Focused Ultrasound Center of Excellence, welcoming the institution into a global community committed to advancing focused ultrasound technology for the benefit of patients. Learn more: https://ow.ly/IPM950XMrmK

NASA engineer Victor Murray approached his prostate cancer diagnosis like any challenge: find the best solution. Focused ultrasound was that solution — a 90-minute, same-day treatment. Now he’s advocating for greater awareness and access. Read his story: https://ow.ly/arUA50XHzzA